Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly Treasury Shares of $402807.0 for Q1 2026, little changed quarter-over-quarter from $403000.0 in Q3 2024.
Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported Treasury Shares for 6 consecutive years, with $402807.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed N/A year-over-year to $402807.0; the TTM figure through Mar 2026 stood at $402807.0 (changed N/A YoY), while the FY2023 annual figure was $403000.0, down 43.24% from the prior year.
- Treasury Shares steadied at $402807.0 in Q1 2026 per OLMA's latest filing, from $403000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $710000.0 in Q4 2022 and bottomed at $40352.0 in Q1 2024.
- Historically, Treasury Shares has averaged $339511.5 across 4 years, with a median of $394548.0 in 2022.
- On a YoY basis, Treasury Shares climbed as much as 172.38% in 2024 and fell as far as 83.64% in 2024.
- Olema Pharmaceuticals' Treasury Shares stood at $710000.0 in 2022, then slumped by 43.24% to $403000.0 in 2023, then changed by 0.0% to $403000.0 in 2024, then declined by 0.05% to $402807.0 in 2026.
- Business Quant data shows OLMA's Treasury Shares at $402807.0 in Q1 2026, $403000.0 in Q3 2024, and $40352.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Olema Pharmaceuticals | 930.10 Mn | 930.10 Mn | - | 398,673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 398,673.00 |
| Jun 30, 2026 | 398,673.00 |
| Mar 31, 2026 | 402,807.00 |
| Mar 31, 2026 | 402,807.00 |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Mar 31, 2024 | 40,352.00 |
| Mar 31, 2024 | 40,352.00 |
| Dec 31, 2023 | 403,000.00 |
| Dec 31, 2023 | 403,000.00 |
| Sep 30, 2023 | 147,956.00 |
| Sep 30, 2023 | 147,956.00 |
| Jun 30, 2023 | 197,274.00 |
| Jun 30, 2023 | 197,274.00 |
| Mar 31, 2023 | 246,593.00 |
| Mar 31, 2023 | 246,593.00 |
| Dec 31, 2022 | 710,000.00 |
| Dec 31, 2022 | 710,000.00 |
| Sep 30, 2022 | 345,230.00 |
| Sep 30, 2022 | 345,230.00 |